Mycobacterial Purified Protein Derivatives Stimulate Innate Immunity: Malawians Show Enhanced Tumor Necrosis Factor Alpha, Interleukin-1β (IL-1β), and IL-10 Responses Compared to Those of Adolescents in the United Kingdom

Infection and Immunity

Volumn 72, Issue 3, 2004, Pages 1807-1811

  Weir, Rosemary E ^a   Black, Gillian F ^a,d   Dockrell, Hazel M ^a   Floyd, Sian ^a   Fine, Paul E M ^a,d   Chaguluka, Steven D ^d   Stenson, Sally ^a   King, Elizabeth ^a   Nazareth, Bernadette ^b   Warndorff, David K ^d   Ngwira, Bagrey ^d   Crampin, Amelia C ^a,d   Mwaungulu, Lorren ^d   Sichali, Lifted ^d   Jarman, Elizabeth ^d   Donovan, Linda ^d   Blackwell, Jenefer M ^c  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b Redbridge Waltham Forest Hlth Auth   (United Kingdom)

^c ADDENBROOKE S HOSPITAL   (United Kingdom)

^d KARONGA PREVENTION STUDY   (Malawi)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 1BETA; PLACEBO; TUBERCULIN; TUMOR NECROSIS FACTOR ALPHA;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; BCG VACCINATION; CONTROLLED STUDY; HUMAN; IMMUNITY; MAJOR CLINICAL STUDY; MALAWI; MYCOBACTERIUM BOVIS; PRIORITY JOURNAL; UNITED KINGDOM;

ADAPTATION, PHYSIOLOGICAL; ADOLESCENT; ADULT; BCG VACCINE; CHILD; GREAT BRITAIN; HUMANS; IMMUNITY, NATURAL; INTERLEUKIN-1; INTERLEUKIN-10; LIPOPOLYSACCHARIDES; MALAWI; TUBERCULIN; TUBERCULOSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 10744229595     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.72.3.1807-1811.2004     Document Type: Article

References (24)

1. Akira, S., K. Takeda, and T. Kaisho. 2001. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat. Immunol. 2:675-680.
2. Bendelac, A., and D. T. Fearon. 1997. Innate pathways that control acquired immunity. Curr. Opin. Immunol. 9:1-3.
3. Black, G. F., H. M. Dockrell, A. C. Crampin, S. Floyd, R. E. Weir, L. Bliss, L. Sichali, L. Mwaungulu, H. Kanyongoloka, B. Ngwira, D. K. Warndorff, and P. E. Fine. 2001. Patterns and implications of naturally acquired immune responses to environmental and tuberculous mycobacterial antigens in northern Malawi. J. Infect. Dis. 184:322-329.
4. Black, G. F., P. E. M. Fine, D. K. Warndorff, S. Floyd, R. E. Weir, J. M. Blackwell, L. Bliss, L. Sichali, L. Mwaungulu, S. Chaguluka, E. Jarman, B. Ngwira, and H. M. Dockrell. 2001. Relationship between IFN-gamma and skin test responsiveness to Mycobacterium tuberculosis PPD in healthy, non-BCG-vaccinated young adults in northern Malawi. Int. J. Tuberc. Lung Dis. 5:664-672.
5. Black, G. F., R. E. Weir, S. Floyd, L. Bliss, D. K. Warndorff, A. C. Crampin, B. Ngwira, L. Sichali, B. Nazareth, J. M. Blackwell, K. Branson, S. D. Chaguluka, L. Donovan, E. Jarman, E. King, P. E. Fine, and H. M. Dockrell. 2002. BCG-induced increase in interferon-gamma response to mycobacterial antigens and efficacy of BCG vaccination in Malawi and the UK: two randomised controlled studies. Lancet 359:1393-1401.
6. Edwards, L. B., and C. E. Palmer. 1958. Epidemiologic studies of tuberculin sensitivity. 1. Preliminary results with purified protein derivatives prepared from atypical acid-fast organisms. Am. J. Hyg. 68:213-231.
7. Fearon, D. T. 2000. Innate immunity-beginning to fulfill its promise? Nat. Immunol. 1:102-103.
8. Fearon, D. T. 1997. Seeking wisdom in innate immunity. Nature 388:323-324.
9. Fearon, D. T., and R. M. Locksley. 1996. The instructive role of innate immunity in the acquired immune response. Science 272:50-53.
10. Fine, P. E. 1995. Variation in protection by BCG: implications of and for heterologous immunity. Lancet 346:1339-1345.
11. Foey, A. D., S. L. Parry, L. M. Williams, M. Feldmann, B. M. Foxwell, and F. M. Brennan. 1998. Regulation of monocyte IL-10 synthesis by endogenous IL-1 and TNF-alpha: role of the p38 and p42/44 mitogen-activated protein kinases. J. Immunol. 160:920-928.
12. Kaur, D., T. L. Lowary, V. D. Vissa, D. C. Crick, and P. J. Brennan. 2002. Characterization of the epitope of anti-lipoarabinomannan antibodies as the terminal hexaarabinofuranosyl motif of mycobacterial arabinans. Microbiology 148:3049-3057.
13. Khoo, K. H., A. Dell, H. R. Morris, P. J. Brennan, and D. Chatterjee. 1995. Inositol phosphate capping of the nonreducing termini of lipoarabinomannan from rapidly growing strains of Mycobacterium. J. Biol. Chem. 270:12380-12389.
14. Khoo, K. H., J. B. Tang, and D. Chatterjee. 2001. Variation in mannosecapped terminal arabinan motifs of lipoarabinomannans from clinical isolates of Mycobacterium tuberculosis and Mycobacterium avium complex. J. Biol. Chem. 276:3863-3871.
15. Magnusson, M., and M. W. Bentzon. 1958. Preparation of purified tuberculin RT23. Bull. W. H. O. 19:829-843.
16. Means, T. K., E. Lien, A. Yoshimura, S. Wang, D. T. Golenbock, and M. J. Fenton. 1999. The CD14 ligands lipoarabinomannan and lipopolysaccharide differ in their requirement for Toll-like receptors. J. Immunol. 163:6748-6755.
17. Means, T. K., S. Wang, E. Lien, A. Yoshimura, D. T. Golenbock, and M. J. Fenton. 1999. Human toll-like receptors mediate cellular activation by Mycobacterium tuberculosis. J. Immunol. 163:3920-3927.
18. Medzhitov, R., and C. A. Janeway, Jr. 1997. Innate immunity: impact on the adaptive immune response. Curr. Opin. Immunol. 9:4-9.
19. Medzhitov, R., and C. A. Janeway, Jr. 1997. Innate immunity: the virtues of a nonclonal system of recognition. Cell 91:295-298.
20. Stanford, J. L., G. A. Rook, N. Samuel, F. Madlener, A. A. Khamenei, T. Nemati, F. Modabber, and R. J. Rees. 1980. Preliminary immunological studies in search of correlates of protective immunity carried out on some Iranian leprosy patients and their families. Lepr. Rev. 51:303-314.
21. Stenger, S., and R. L. Modlin. 2002. Control of Mycobacterium tuberculosis through mammalian Toll-like receptors. Curr. Opin. Immunol. 14:452-457.
22. Takeda, K., T. Kaisho, and S. Akira. 2003. Toll-like receptors. Annu. Rev. Immunol. 21:335-376.
23. Weir, R. E., P. E. M. Fine, B. Nazareth, S. Floyd, G. F. Black, E. King, C. Stanley, L. Bliss, K. Branson, and H. M. Dockrell. 2003. Interferon-gamma and skin test responses of schoolchildren in southeast England to purified protein derivatives from Mycobacterium tuberculosis and other species of mycobacteria. Clin. Exp. Immunol. 134:285-294.
24. World Health Organization. 1955. International standard for purified protein derivative of avian tuberculin. WHO Tech. Rep. Ser. 96:11.